|
Age (mean (sd))
|
7.0 (4.5)
|
|
Female (%)
|
40%
|
|
White Race (%)
|
68%
|
|
Black Race (%)
|
11%
|
|
Other Race (%)
|
22%
|
|
Elapsed Days Since Onset of Symptoms (mean (sd))
|
40 (46)
|
|
Elapsed Days Since Diagnosis (mean (sd))
|
6 (8)
|
|
Physician Global Assessment (mean (sd))
|
5.9 (2.2)
|
|
Parent Global Assessment (mean (sd))
|
5.1 (3.3)
|
|
Number of Active Joints (mean (sd))
|
6.4 (8.0)
|
|
sJIA rash (%)
|
85%
|
|
Generalized lymphadenopathy (%)
|
25%
|
|
Hepatomegaly (%)
|
15%
|
|
Splenomegaly (%)
|
15%
|
|
Serositis (%)
|
13%
|
|
Morning Stiffness >15 minutes (%)
|
37%
|
|
ESR (median (IQR))
|
71 (44-100)
|
|
C-RP (median (IQR))
|
12.3 (6.2-53.3)
|
|
Ferritin (median (IQR))
|
700 (236-1266)
|
|
Hemoglobin (median (IQR))
|
10.1 (9.1-11.1)
|
|
WBC (median (IQR))
|
14.7 (9.8-20.2)
|
|
Platelets (median (IQR))
|
453 (335-564)
|
|
AST (median (IQR))
|
34 (23-46)
|
|
ALT (median (IQR))
|
33 (16-51)
|
|
CHAQ (mean (sd))
|
1.1 (0.9)
|
|
Pain VAS (mean (sd))
|
2.9 (2.7)
|
